Astera Labs Attracts and Loses Institutional Investor Interest

Principal Financial Group Inc. reduced its holdings by 44.6% during Q1 2025.

Morse Asset Management Inc lowered its stake by 10.3% in Q1 2025.

TimesSquare Capital Management LLC trimmed its holdings by 87.2% in Q1 2025.

Several firms, including Whittier Trust Co. of Nevada Inc., Murphy & Mullick Capital Management Corp, Sound Income Strategies LLC, GAMMA Investing LLC, NewEdge Advisors LLC, HighTower Advisors LLC, Commonwealth Equity Services LLC, Natixis Advisors LLC, Envestnet Portfolio Solutions Inc., Thrivent Financial for Lutherans, Steward Partners Investment Advisory LLC, Hoey Investments Inc., and Allworth Financial LP acquired new positions or increased their stakes during Q4 2024 and Q1 2025.

Insiders have sold 1,965,984 shares of company stock valued at $178,631,873 in the last ninety days.

Wall Street analysts have a consensus rating of "Moderate Buy" with an average price target of $100.71.

Decreased Positions:: Principal Financial Group Inc., Morse Asset Management Inc, and TimesSquare Capital Management LLC reduced their holdings in Q1 2025.

Increased Positions:: Several other firms increased their positions or initiated new stakes during the same period. This mixed activity suggests differing opinions on the company's short-term prospects.

Recent insider sales, including those by Director Bethany Mayer, COO Sanjay Gajendra, Director Manuel Alba, CFO Michael Truett Tate, and CEO Jitendra Mohan, indicate a decrease in insider ownership.

Wall Street analysts have a consensus rating of "Moderate Buy" for Astera Labs, with an average price target of $100.71. However, there have been some recent downgrades, such as Wall Street Zen cutting the rating from "buy" to "hold". Other firms like Needham & Company LLC decreased their price objective, while Evercore ISI lifted their target price. Barclays raised their price objective from $70.00 to $75.00, giving the stock an "overweight" rating in a research note on Wednesday, May 7th&ref=yanuki.com. William Blair initiated coverage on Astera Labs in a research note on Thursday, May 22nd&ref=yanuki.com. They set an "outperform" rating on the stock. Susquehanna initiated coverage on Astera Labs in a research note on Friday, May 16th&ref=yanuki.com. They set a "neutral" rating and a $80.00 price objective on the stock. Finally, Roth Capital set a $100.00 price objective on Astera Labs and gave the stock a "buy" rating in a research note on Wednesday, May 7th&ref=yanuki.com.

Astera Labs' stock has experienced volatility, with a 52-week low of $36.22 and a 52-week high of $147.39.

The stock opened at $102.13 on Monday.

The business has a 50 day moving average of $92.81 and a two-hundred day moving average of $86.33.

Q: What is Astera Labs' business?

Q: What is the analyst consensus rating for Astera Labs?

Q: Has there been insider selling activity recently?

Institutional investor activity in Astera Labs is mixed, with some firms increasing their stakes while others reduced theirs.

Insider selling activity has been notable, indicating a potential lack of confidence among company executives.

Analysts have a generally positive outlook on the stock, but there have been some recent downgrades.

Astera Labs operates in the growing AI infrastructure market, which could drive future growth.